{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:25:53Z","timestamp":1784075153794,"version":"3.55.0"},"reference-count":95,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2024,6,28]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>High-flow nasal oxygen therapy (HFNO) is used in diverse hospital settings to treat patients with acute respiratory failure (ARF). This systematic review aims to summarise the evidence regarding any benefits HFNO therapy has compared with conventional oxygen therapy (COT) for patients with ARF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Three databases (Embase, Medline and CENTRAL) were searched on 22 March 2023 for studies evaluating HFNO compared with COT for the treatment of ARF, with the primary outcome being hospital mortality and secondary outcomes including (but not limited to) escalation to invasive mechanical ventilation (IMV) or non-invasive ventilation (NIV). Risk of bias was assessed using the Cochrane risk-of-bias tool (randomised controlled trials (RCTs)), ROBINS-I (non-randomised trials) or Newcastle-Ottawa Scale (observational studies). RCTs and observational studies were pooled together for primary analyses, and secondary analyses used RCT data only. Treatment effects were pooled using the random effects model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>63 studies (26 RCTs, 13 cross-over and 24 observational studies) were included, with 10\u2009230 participants. There was no significant difference in the primary outcome of hospital mortality (risk ratio, RR 1.08, 95%\u2009CI 0.93 to 1.26; p=0.29; 17 studies, n=5887) between HFNO and COT for all causes ARF. However, compared with COT, HFNO significantly reduced the overall need for escalation to IMV (RR 0.85, 95% CI 0.76 to 0.95 p=0.003; 39 studies, n=8932); and overall need for escalation to NIV (RR 0.70, 95% CI 0.50 to 0.98; p=0.04; 16 studies, n=3076). In subgroup analyses, when considering patients by illness types, those with acute-on-chronic respiratory failure who received HFNO compared with COT had a significant reduction in-hospital mortality (RR 0.58, 95% CI 0.37 to 0.91; p=0.02).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>HFNO was superior to COT in reducing the need for escalation to both IMV and NIV but had no impact on the primary outcome of hospital mortality. These findings support recommendations that HFNO may be considered as first-line therapy for ARF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42021264837.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-002342","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T14:20:10Z","timestamp":1721053210000},"page":"e002342","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["High-flow nasal oxygen therapy compared with conventional oxygen therapy in hospitalised patients with respiratory illness: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7390-6714","authenticated-orcid":false,"given":"Daniel","family":"Seow","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Sengkang General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yet H","family":"Khor","sequence":"additional","affiliation":[{"name":"Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Victoria, Australia"},{"name":"Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Wei","family":"Khung","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Smallwood","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Western Health, Footscray, Victoria, Australia"},{"name":"Department of Medical Education, University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Ng","sequence":"additional","affiliation":[{"name":"Monash Lung, Sleep, Allergy and Immunology, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3555-6856","authenticated-orcid":false,"given":"Amy","family":"Pascoe","sequence":"additional","affiliation":[{"name":"Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Smallwood","sequence":"additional","affiliation":[{"name":"Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Victoria, Australia"},{"name":"Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"2025083111003569000_11.1.e002342.1","doi-asserted-by":"crossref","unstructured":"Frat J-P , Coudroy R , Marjanovic N , et al . High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure. Ann Transl Med 2017;5. doi:10.21037\/atm.2017.06.52","DOI":"10.21037\/atm.2017.06.52"},{"key":"2025083111003569000_11.1.e002342.2","unstructured":"Sharma S , Danckers M , Sanghavi D , et al . High flow nasal Cannula. In: StatPearls. Treasure Island (FL), 2022."},{"key":"2025083111003569000_11.1.e002342.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-0916OC"},{"key":"2025083111003569000_11.1.e002342.4","doi-asserted-by":"crossref","unstructured":"Pacheco E , Wawrzeniak IC , Victorino JA , et al . Physiological effects of high flow nasal therapy in patients with acute respiratory failure measured by esophageal catheter and electrical impedance tomography: a pilot study. Am J Respir Crit Care Med 2019;119. doi:10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A2735","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A2735"},{"key":"2025083111003569000_11.1.e002342.5","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1097\/CCM.0000000000002693","article-title":"Effects of high-flow nasal cannula on the work of breathing in patients recovering from acute respiratory failure","volume":"45","author":"Delorme","year":"2017","journal-title":"Crit Care Med"},{"key":"2025083111003569000_11.1.e002342.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201402-0364OC"},{"key":"2025083111003569000_11.1.e002342.7","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.01575"},{"key":"2025083111003569000_11.1.e002342.8","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04252"},{"key":"2025083111003569000_11.1.e002342.9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jcrc.2011.07.075","article-title":"Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study","volume":"27","author":"Sztrymf","year":"2012","journal-title":"J Crit Care"},{"key":"2025083111003569000_11.1.e002342.10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.7326\/M20-4675","article-title":"Effectiveness and harms of high-flow nasal oxygen for acute respiratory failure: an evidence report for a clinical guideline from the American college of physicians","volume":"174","author":"Baldomero","year":"2021","journal-title":"Ann Intern Med"},{"key":"2025083111003569000_11.1.e002342.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.9524"},{"key":"2025083111003569000_11.1.e002342.12","doi-asserted-by":"crossref","unstructured":"Huang C-C , Lan H-M , Li C-J , et al . Use high-flow nasal cannula for acute respiratory failure patients in the emergency department: a meta-analysis study. Emerg Med Int 2019;2019. doi:10.1155\/2019\/2130935","DOI":"10.1155\/2019\/2130935"},{"key":"2025083111003569000_11.1.e002342.13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.rmed.2016.11.004","article-title":"High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: a systematic review","volume":"121","author":"Lee","year":"2016","journal-title":"Respir Med"},{"key":"2025083111003569000_11.1.e002342.14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcrc.2016.05.013","article-title":"Comparison of high-flow nasal oxygen therapy with conventional oxygen therapy and noninvasive ventilation in adult patients with acute hypoxemic respiratory failure: a meta-analysis and systematic review","volume":"35","author":"Maitra","year":"2016","journal-title":"J Crit Care"},{"key":"2025083111003569000_11.1.e002342.15","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002091"},{"key":"2025083111003569000_11.1.e002342.16","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04831"},{"key":"2025083111003569000_11.1.e002342.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.07.083"},{"key":"2025083111003569000_11.1.e002342.18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.chest.2017.01.004","article-title":"Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation?: a systematic review and meta-analysis","volume":"151","author":"Ni","year":"2017","journal-title":"Chest"},{"key":"2025083111003569000_11.1.e002342.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05658-2"},{"key":"2025083111003569000_11.1.e002342.20","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.05962"},{"key":"2025083111003569000_11.1.e002342.21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jemermed.2020.01.016","article-title":"Use of high-flow nasal cannula for immunocompromise and acute respiratory failure: a systematic review and meta-analysis","volume":"58","author":"Wang","year":"2020","journal-title":"J Emerg Med"},{"key":"2025083111003569000_11.1.e002342.22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/0885066619844713","article-title":"Noninvasive oxygenation strategies in immunocompromised patients with acute hypoxemic respiratory failure: a pairwise and network meta-analysis of randomized controlled trials","volume":"35","author":"Zayed","year":"2020","journal-title":"J Intensive Care Med"},{"key":"2025083111003569000_11.1.e002342.23","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06981"},{"key":"2025083111003569000_11.1.e002342.24","doi-asserted-by":"crossref","unstructured":"Lewis SR , Baker PE , Parker R , et al . High-flow nasal cannulae for respiratory support in adult intensive care patients. Cochrane Database Syst Rev 2021;3. doi:10.1002\/14651858.CD010172.pub3","DOI":"10.1002\/14651858.CD010172.pub3"},{"key":"2025083111003569000_11.1.e002342.25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1080\/17476348.2021.1937131","article-title":"The effect of high flow nasal oxygen therapy in intensive care units: a systematic review and meta-analysis","volume":"15","author":"Liang","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"2025083111003569000_11.1.e002342.26","doi-asserted-by":"crossref","unstructured":"Oczkowski S , Ergan B , Bos L , et al . ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J 2022;59. doi:10.1183\/13993003.01574-2021","DOI":"10.1183\/13993003.01574-2021"},{"key":"2025083111003569000_11.1.e002342.27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2007LE"},{"key":"2025083111003569000_11.1.e002342.28","doi-asserted-by":"crossref","unstructured":"Bonnet N , Martin O , Boubaya M , et al . High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-Cov-2 pneumonia: a retrospective study. Ann Intensive Care 2021;11. doi:10.1186\/s13613-021-00825-5","DOI":"10.1186\/s13613-021-00825-5"},{"key":"2025083111003569000_11.1.e002342.29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.hrtlng.2021.02.009","article-title":"Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia","volume":"50","author":"Sayan","year":"2021","journal-title":"Heart Lung"},{"key":"2025083111003569000_11.1.e002342.30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","article-title":"Clinical characteristics and Day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study","volume":"47","year":"2021","journal-title":"Intensive Care Med"},{"key":"2025083111003569000_11.1.e002342.31","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2022-218806"},{"key":"2025083111003569000_11.1.e002342.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.15613"},{"key":"2025083111003569000_11.1.e002342.33","doi-asserted-by":"crossref","unstructured":"Gallardo A , D\u00e9voli AP , Ar\u00e9valo GEB , et al . High-flow nasal Cannula and standard oxygen in acute hypoxemic respiratory failure due to COVID-19. Respir Care 2022;19. doi:10.4187\/respcare.10019","DOI":"10.4187\/respcare.10019"},{"key":"2025083111003569000_11.1.e002342.34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajem.2022.10.029","article-title":"Non-Rebreather mask and low-flow nasal Cannula vs high-flow nasal Cannula in severe COVID-19 pneumonia in the emergency department","volume":"63","author":"Mohd Kamil","year":"2023","journal-title":"Am J Emerg Med"},{"key":"2025083111003569000_11.1.e002342.35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7196\/AJTCCM.2022.v28i1.206","article-title":"The effectiveness of high-flow nasal Cannula and standard non-rebreathing mask for oxygen therapy in moderate category COVID-19 pneumonia: randomised controlled trial","volume":"28","author":"Nazir","year":"2022","journal-title":"Afr J Thorac Crit Care Med"},{"key":"2025083111003569000_11.1.e002342.36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.20714"},{"key":"2025083111003569000_11.1.e002342.37","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4103\/ija.ija_507_22","article-title":"A randomised controlled trial of high-flow nasal oxygen versus non-rebreathing oxygen face mask therapy in acute hypoxaemic respiratory failure","volume":"66","author":"Thota","year":"2022","journal-title":"Indian J Anaesth"},{"key":"2025083111003569000_11.1.e002342.38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.ccm.0000726972.98651.8c","article-title":"Outcomes of patients with COVID-19-associated Ards treated with Hfnc vs. conventional oxygen therapy","volume":"49","author":"Stempek","year":"2021","journal-title":"Crit Care Med"},{"key":"2025083111003569000_11.1.e002342.39","doi-asserted-by":"crossref","unstructured":"Teng X-B , Shen Y , Han M-F , et al . The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia. Eur J Clin Invest 2021;51. doi:10.1111\/eci.13435","DOI":"10.1111\/eci.13435"},{"key":"2025083111003569000_11.1.e002342.40","doi-asserted-by":"crossref","unstructured":"Hacquin A , Perret M , Manckoundia P , et al . High-flow nasal cannula oxygenation in older patients with SARS-Cov-2-related acute respiratory failure. J Clin Med 2021;10. doi:10.3390\/jcm10163515","DOI":"10.3390\/jcm10163515"},{"key":"2025083111003569000_11.1.e002342.41","doi-asserted-by":"crossref","unstructured":"Delbove A , Foubert A , Mateos F , et al . High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation. Ther Adv Respir Dis 2021;15. doi:10.1177\/17534666211019555","DOI":"10.1177\/17534666211019555"},{"key":"2025083111003569000_11.1.e002342.42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.2022.0028","article-title":"Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial","volume":"327","author":"Perkins","year":"2022","journal-title":"JAMA"},{"key":"2025083111003569000_11.1.e002342.43","doi-asserted-by":"publisher","DOI":"10.1097\/mcc.0000000000001001"},{"key":"2025083111003569000_11.1.e002342.44","doi-asserted-by":"crossref","unstructured":"Li J , Fink JB , Ehrmann S . High-flow nasal Cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J 2020;55. doi:10.1183\/13993003.00892-2020","DOI":"10.1183\/13993003.00892-2020"},{"key":"2025083111003569000_11.1.e002342.45","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s11606-022-07949-9","article-title":"Effect of ward-based high-flow nasal Cannula (HFNC) oxygen therapy on critical care utilization during the COVID-19 pandemic: a retrospective cohort analysis","volume":"38","author":"Silverstein","year":"2023","journal-title":"J Gen Intern Med"},{"key":"2025083111003569000_11.1.e002342.46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jcm12123911","article-title":"International survey of high-flow nasal therapy use for respiratory failure in adult patients","volume":"12","author":"Alnajada","year":"2023","journal-title":"J Clin Med"},{"key":"2025083111003569000_11.1.e002342.47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025083111003569000_11.1.e002342.48","first-page":"01","article-title":"The use of high-flow nasal oxygen vs. standard oxygen therapy in hematological malignancy patients with acute respiratory failure in hematology wards","volume":"01","author":"Alptekinoglu","year":"2021","journal-title":"Turk J Med Sci"},{"key":"2025083111003569000_11.1.e002342.49","doi-asserted-by":"crossref","unstructured":"Andino R , Vega G , Pacheco SK , et al . High-flow nasal oxygen reduces endotracheal intubation: a randomized clinical trial. Ther Adv Respir Dis 2020;14. doi:10.1177\/1753466620956459","DOI":"10.1177\/1753466620956459"},{"key":"2025083111003569000_11.1.e002342.50","doi-asserted-by":"crossref","unstructured":"Arman PD , Varn MN , Povian S , et al . Effects of direct extubation to high-flow nasal cannula compared to standard nasal cannula in patients in the intensive care unit. Am J Respir Crit Care Med 2017. doi:10.1186\/s13054-016-1208-6","DOI":"10.1186\/s13054-016-1208-6"},{"key":"2025083111003569000_11.1.e002342.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.14282"},{"key":"2025083111003569000_11.1.e002342.52","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","article-title":"Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"key":"2025083111003569000_11.1.e002342.53","first-page":"108","article-title":"Nasal high flow oxygen for community-acquired pneumonia","volume":"17","author":"Ellison","year":"2016","journal-title":"J Intensive Care Soc"},{"key":"2025083111003569000_11.1.e002342.54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503326"},{"key":"2025083111003569000_11.1.e002342.55","unstructured":"Gedikloglu M , Gulen M , Satar S , et al . How to treat patients with acute respiratory failure? conventional oxygen therapy versus high-flow nasal Cannula in the emergency department. Hong Kong J Emerg Med 2019."},{"key":"2025083111003569000_11.1.e002342.56","first-page":"36","article-title":"Effect of high-flow nasal oxygen vs. conventional oxygen therapy on extubation outcomes and physiologic changes for patients with high risk of extubation failure in the medical ICU: a tertiary center, randomized, controlled trial","volume":"14","author":"Hu","year":"2020","journal-title":"Int J Gerontol"},{"key":"2025083111003569000_11.1.e002342.57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4266\/acc.2018.00311","article-title":"Protecting postextubation respiratory failure and reintubation by high-flow nasal cannula compared to low-flow oxygen system: single center retrospective study and literature review","volume":"34","author":"Lee","year":"2019","journal-title":"Acute Crit Care"},{"key":"2025083111003569000_11.1.e002342.58","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1097\/CCM.0000000000004456","article-title":"Oxygenation strategy during acute respiratory failure in critically ill immunocompromised patients","volume":"48","author":"Lemiale","year":"2020","journal-title":"Crit Care Med"},{"key":"2025083111003569000_11.1.e002342.59","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1097\/CCM.0000000000002085","article-title":"High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a groupe de recherche respiratoire en reanimation onco-hematologique study","volume":"45","author":"Lemiale","year":"2017","journal-title":"Crit Care Med"},{"key":"2025083111003569000_11.1.e002342.60","doi-asserted-by":"crossref","unstructured":"Lemiale V , Mokart D , Mayaux J , et al . The effects of a 2-H trial of high-flow oxygen by nasal cannula versus venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial. Crit Care 2015;19. doi:10.1186\/s13054-015-1097-0","DOI":"10.1186\/s13054-015-1097-0"},{"key":"2025083111003569000_11.1.e002342.61","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.ajem.2019.03.004","article-title":"Early high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure in the ED: a before-after study","volume":"37","author":"Mac\u00e9","year":"2019","journal-title":"Am J Emerg Med"},{"key":"2025083111003569000_11.1.e002342.62","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03837"},{"key":"2025083111003569000_11.1.e002342.63","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02397"},{"key":"2025083111003569000_11.1.e002342.64","first-page":"408","article-title":"High-flow oxygen therapy in acute respiratory failure","volume":"55","author":"Roca","year":"2010","journal-title":"Respir Care"},{"key":"2025083111003569000_11.1.e002342.65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.annemergmed.2019.09.009","article-title":"High-flow nasal cannula versus conventional oxygen therapy in relieving dyspnea in emergency palliative patients with do-not-Intubate status: a randomized crossover study","volume":"75","author":"Ruangsomboon","year":"2020","journal-title":"Ann Emerg Med"},{"key":"2025083111003569000_11.1.e002342.66","doi-asserted-by":"crossref","unstructured":"Schwabbauer N , Berg B , Blumenstock G , et al . Nasal high-flow oxygen therapy in patients with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation (NIV). BMC Anesth 2014;14. doi:10.1186\/1471-2253-14-66","DOI":"10.1186\/1471-2253-14-66"},{"key":"2025083111003569000_11.1.e002342.67","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6061\/clinics\/2017(09)07","article-title":"The value of high-flow nasal cannula oxygen therapy after extubation in patients with acute respiratory failure","volume":"72","author":"Song","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"key":"2025083111003569000_11.1.e002342.68","doi-asserted-by":"crossref","first-page":"3000605211022279","DOI":"10.1177\/03000605211022279","article-title":"Comparison of high-flow nasal oxygen cannula therapy versus a standard oxygen face mask in patients with hypostatic pneumonia","volume":"49","author":"Song","year":"2021","journal-title":"J Int Med Res"},{"key":"2025083111003569000_11.1.e002342.69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcrc.2018.10.004","article-title":"High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: a pilot randomized controlled trial","volume":"48","author":"Spoletini","year":"2018","journal-title":"J Crit Care"},{"key":"2025083111003569000_11.1.e002342.70","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03814"},{"key":"2025083111003569000_11.1.e002342.71","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-1539"},{"key":"2025083111003569000_11.1.e002342.72","doi-asserted-by":"crossref","unstructured":"Xing D , Chen Y-H , Wang L-T , et al . Evaluation of the therapeutic effect of high-flow nasal cannula oxygen therapy on patients with aspiration pneumonia accompanied by respiratory failure in the post-stroke sequelae stage. BMC Pulm Med 2021;21. doi:10.1186\/s12890-020-01359-5","DOI":"10.1186\/s12890-020-01359-5"},{"key":"2025083111003569000_11.1.e002342.73","doi-asserted-by":"crossref","unstructured":"Branick K , Jackson JA , McCann D , et al . Use of nasal high flow oxygen on the general medical floor can prevent ICU admission and escalation of care in COPD patients. American Journal of Respiratory and Critical Care Medicine; 2019","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A2733"},{"key":"2025083111003569000_11.1.e002342.74","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/15412555.2020.1728736","article-title":"High flow nasal therapy use in patients with acute exacerbation of COPD and bronchiectasis: a feasibility study","volume":"17","author":"Crimi","year":"2020","journal-title":"COPD"},{"key":"2025083111003569000_11.1.e002342.75","doi-asserted-by":"crossref","unstructured":"Di Mussi R , Spadaro S , Stripoli T , et al . High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. critical care. Crit Care 2018;22. doi:10.1186\/s13054-018-2107-9","DOI":"10.1186\/s13054-018-2107-9"},{"key":"2025083111003569000_11.1.e002342.76","doi-asserted-by":"crossref","unstructured":"Geng W , Batu W , You S , et al . High-flow nasal cannula: a promising oxygen therapy for patients with severe bronchial asthma complicated with respiratory failure. Can Respir J 2020;2020. doi:10.1155\/2020\/2301712","DOI":"10.1155\/2020\/2301712"},{"key":"2025083111003569000_11.1.e002342.77","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/COPD.S283020","article-title":"High-flow nasal cannula for chronic obstructive pulmonary disease with acute compensated hypercapnic respiratory failure: a randomized, controlled trial","volume":"15","author":"Li","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083111003569000_11.1.e002342.78","first-page":"615","article-title":"Value and safety of high flow oxygenation in the treatment of inpatient asthma: a randomized, double-blind, pilot study","volume":"18","author":"Raeisi","year":"2019","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"2025083111003569000_11.1.e002342.79","doi-asserted-by":"crossref","unstructured":"Piquilloud L , Beloncle F , Olivier PY , et al . Nasal high flow oxygen can be used in hypercapnic respiratory failure due to COPD exacerbation without increase in Paco2. Ann Intensive Care Conf French Intensive Care Soc Int Congr 2020;10. doi:10.1186\/s13613-020-0623-7","DOI":"10.1186\/s13613-020-0623-7"},{"key":"2025083111003569000_11.1.e002342.80","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/resp.13050","article-title":"Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial","volume":"22","author":"Pilcher","year":"2017","journal-title":"Respirology"},{"key":"2025083111003569000_11.1.e002342.81","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/acem.14187","article-title":"Nasal high-flow oxygen versus conventional oxygen therapy for acute severe asthma patients: a pilot randomized controlled trial","volume":"28","author":"Ruangsomboon","year":"2021","journal-title":"Acad Emerg Med"},{"key":"2025083111003569000_11.1.e002342.82","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/TP.0000000000000460","article-title":"Humidified high flow nasal cannula supportive therapy improves outcomes in lung transplant recipients readmitted to the intensive care unit because of acute respiratory failure","volume":"99","author":"Roca","year":"2015","journal-title":"Transplantation"},{"key":"2025083111003569000_11.1.e002342.83","doi-asserted-by":"crossref","unstructured":"Saeed A , Wagih K , Huusein N . Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations. Annual Congress 2015; September 2015 doi:10.1183\/13993003.congress-2015.PA2170","DOI":"10.1183\/13993003.congress-2015.PA2170"},{"key":"2025083111003569000_11.1.e002342.84","doi-asserted-by":"crossref","unstructured":"Xia J , Gu S , Lei W , et al . High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial. Crit Care 2022;26. doi:10.1186\/s13054-022-03973-7","DOI":"10.1186\/s13054-022-04022-z"},{"key":"2025083111003569000_11.1.e002342.85","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.01887"},{"key":"2025083111003569000_11.1.e002342.86","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.01681"},{"key":"2025083111003569000_11.1.e002342.87","doi-asserted-by":"crossref","first-page":"33682","DOI":"10.18632\/oncotarget.26069","article-title":"Oxygenation\/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure","volume":"9","author":"Dumas","year":"2018","journal-title":"Oncotarget"},{"key":"2025083111003569000_11.1.e002342.88","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00134-017-4890-1","article-title":"Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates","volume":"43","author":"Mauri","year":"2017","journal-title":"Intensive Care Med"},{"key":"2025083111003569000_11.1.e002342.89","doi-asserted-by":"crossref","unstructured":"Le Pape S , Savart S , Arriv\u00e9 F , et al . High-flow nasal cannula oxygen versus conventional oxygen therapy for acute respiratory failure due to COVID-19: a systematic review and meta-analysis. Ann Intensive Care 2023;13. doi:10.1186\/s13613-023-01208-8","DOI":"10.1186\/s13613-023-01208-8"},{"key":"2025083111003569000_11.1.e002342.90","doi-asserted-by":"crossref","unstructured":"Santamarina MG , Boisier D , Contreras R , et al . COVID-19: a hypothesis regarding the ventilation-perfusion mismatch. Crit Care 2020;24. doi:10.1186\/s13054-020-03125-9","DOI":"10.1186\/s13054-020-03125-9"},{"key":"2025083111003569000_11.1.e002342.91","doi-asserted-by":"crossref","unstructured":"Allado E , Poussel M , Valentin S , et al . The fundamentals of respiratory physiology to manage the COVID-19 pandemic: an overview. Front Physiol 2020;11. doi:10.3389\/fphys.2020.615690","DOI":"10.3389\/fphys.2020.615690"},{"key":"2025083111003569000_11.1.e002342.92","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.09056"},{"key":"2025083111003569000_11.1.e002342.93","doi-asserted-by":"crossref","unstructured":"Weaver L , Das A , Saffaran S , et al . High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study. Ann Intensive Care 2021;11. doi:10.1186\/s13613-021-00904-7","DOI":"10.1186\/s13613-021-00904-7"},{"key":"2025083111003569000_11.1.e002342.94","doi-asserted-by":"crossref","unstructured":"Colombo SM , Scaravilli V , Cortegiani A , et al . Use of high flow nasal cannula in patients with acute respiratory failure in general wards under intensivists supervision: a single center observational study. Respir Res 2022;23. doi:10.1186\/s12931-022-02090-x","DOI":"10.1186\/s12931-022-02090-x"},{"key":"2025083111003569000_11.1.e002342.95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/CCM.0000000000006068","article-title":"Safety and outcome of high-flow nasal oxygen therapy outside ICU setting in hypoxemic patients with COVID-19","volume":"52","author":"Janssen","year":"2024","journal-title":"Crit Care Med"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:00:54Z","timestamp":1756663254000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7,15]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bmjresp-2024-002342"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002342","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}